Gross margin from €27,360 to €45,212Result from €14,177 to €25,820Dividend €72,144Equity from €75,144 to €28,820Debts from €18,029 to €6,026Cash from €61,842 to €6,951
Higher solvency than 89% of companies in retail trade. The sector median is 33.2%, over 25,428 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 26,977 companies had the same profile as PHARMAVANTY has now. Each dot stands for 68 companies, two years later.
94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
Micro
5 to 10 years old
solvency 30% or more
a profit of 5% of the balance sheet or more
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,977 companies, not a prediction for PHARMAVANTY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0752751474
Incorporation
Founding capital of €3,000, 100 shares · Founded by Name after signing inVisible after signing in (comparant oprichter) · Name hiddenVisible after signing in appointed as director · published on 21-08-2020 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as PHARMAVANTY: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €39,700 and €53,800, founded between 2018 and 2022.
The company number of PHARMAVANTY is 0752.751.474. The VAT number is the same number with BE in front: BE 0752.751.474.
Where is PHARMAVANTY based?
The registered office is at Zevenhoek 12, 9400 Ninove.Company details
What does PHARMAVANTY do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMAVANTY?
PHARMAVANTY is a private limited company (BV).
When was PHARMAVANTY founded?
PHARMAVANTY was founded on 19-08-2020.
Is PHARMAVANTY still active?
Yes, PHARMAVANTY is an active enterprise in the KBO register.
What is the turnover of PHARMAVANTY?
The turnover in financial year 2025 is about €210,000. This figure is estimated from the gross margin of €45,212 and 56 comparable companies (NACE 477). It probably lies between €110,000 and €370,000.Financials
Is PHARMAVANTY profitable?
In financial year 2025, PHARMAVANTY made a profit of €25,820.
Where can I find the annual accounts of PHARMAVANTY?
PHARMAVANTY filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMAVANTY due?
PHARMAVANTY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline